{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T21:12:25Z","timestamp":1788642745656,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12648-3","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T08:39:49Z","timestamp":1788597589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ellagic acid and bone health: a systematic review of preclinical studies on its protective role against osteoporosis"],"prefix":"10.1007","volume":"53","author":[{"given":"Masoomeh","family":"Gholizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnam Omidi","family":"Sarajar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahanbakhsh","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Akbar","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,5]]},"reference":[{"issue":"1","key":"12648_CR1","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.3928\/01477447-20220719-03","volume":"46","author":"SA Sabri","year":"2023","unstructured":"Sabri SA, Chavarria JC, Ackert-Bicknell C, Swanson C, Burger E (2023) Osteoporosis: an update on screening, diagnosis, evaluation, and treatment. Orthopedics 46(1):e20\u2013e26. https:\/\/doi.org\/10.3928\/01477447-20220719-03","journal-title":"Orthopedics"},{"issue":"9","key":"12648_CR2","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.3390\/cells9092073","volume":"9","author":"J-M Kim","year":"2020","unstructured":"Kim J-M, Lin C, Stavre Z, Greenblatt MB, Shim J-H (2020) Osteoblast-osteoclast communication and bone homeostasis. Cells 9(9):2073. https:\/\/doi.org\/10.3390\/cells9092073","journal-title":"Cells"},{"issue":"3","key":"12648_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ecl.2012.04.006","volume":"41","author":"LAG Armas","year":"2012","unstructured":"Armas LAG, Recker RR (2012) Pathophysiology of osteoporosis: new mechanistic insights. Endocrinol Metab Clin 41(3):475\u2013486. https:\/\/doi.org\/10.1016\/j.ecl.2012.04.006","journal-title":"Endocrinol Metab Clin"},{"issue":"2","key":"12648_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21926\/obm.geriatr.2402277","volume":"8","author":"B Foroutan","year":"2024","unstructured":"Foroutan B (2024) Osteoporosis Etiology, Epidemiology, Diagnosis, Diet, and Treatment: A Narrative Review. OBM Geriatr 8(2):1\u201360. https:\/\/doi.org\/10.21926\/obm.geriatr.2402277","journal-title":"OBM Geriatr"},{"key":"12648_CR5","doi-asserted-by":"publisher","unstructured":"KULKARNI SL, Kour H (2024) Narrative review on osteoporosis: a silent killer. J Clin Diagn Res 18(4). https:\/\/doi.org\/10.7860\/JCDR\/2024\/69058.19248","DOI":"10.7860\/JCDR\/2024\/69058.19248"},{"key":"12648_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.actbio.2022.11.051","volume":"157","author":"S Blouin","year":"2023","unstructured":"Blouin S, Misof BM, M\u00e4hr M, Fratzl-Zelman N, Roschger P, Lueger S et al (2023) Osteocyte lacunae in transiliac bone biopsy samples across life span. Acta Biomater 157:275\u2013287. https:\/\/doi.org\/10.1016\/j.actbio.2022.11.051","journal-title":"Acta Biomater"},{"issue":"8","key":"12648_CR7","doi-asserted-by":"publisher","first-page":"e657","DOI":"10.1002\/mco2.657","volume":"5","author":"Z Wu","year":"2024","unstructured":"Wu Z, Li W, Jiang K, Lin Z, Qian C, Wu M et al (2024) Regulation of bone homeostasis: signaling pathways and therapeutic targets. MedComm 5(8):e657. https:\/\/doi.org\/10.1002\/mco2.657","journal-title":"MedComm"},{"issue":"1","key":"12648_CR8","doi-asserted-by":"publisher","first-page":"6891","DOI":"10.1038\/s41467-021-27273-w","volume":"12","author":"S Zhou","year":"2021","unstructured":"Zhou S, Dai Q, Huang X, Jin A, Yang Y, Gong X et al (2021) STAT3 is critical for skeletal development and bone homeostasis by regulating osteogenesis. Nat Commun 12(1):6891. https:\/\/doi.org\/10.1038\/s41467-021-27273-w","journal-title":"Nat Commun"},{"key":"12648_CR9","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.bone.2019.01.018","volume":"121","author":"M Almeida","year":"2019","unstructured":"Almeida M, Porter RM (2019) Sirtuins and FoxOs in osteoporosis and osteoarthritis. Bone 121:284\u2013292. https:\/\/doi.org\/10.1016\/j.bone.2019.01.018","journal-title":"Bone"},{"issue":"4","key":"12648_CR10","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.3390\/ijms24043772","volume":"24","author":"T Iantomasi","year":"2023","unstructured":"Iantomasi T, Romagnoli C, Palmini G, Donati S, Falsetti I, Miglietta F et al (2023) Oxidative stress and inflammation in osteoporosis: molecular mechanisms involved and the relationship with microRNAs. Int J Mol Sci 24(4):3772. https:\/\/doi.org\/10.3390\/ijms24043772","journal-title":"Int J Mol Sci"},{"issue":"2","key":"12648_CR11","first-page":"92","volume":"43","author":"KN Tu","year":"2018","unstructured":"Tu KN, Lie JD, Wan CKV, Cameron M, Austel AG, Nguyen JK et al (2018) Osteoporosis: a review of treatment options. Pharm Ther 43(2):92","journal-title":"Pharm Ther"},{"issue":"9","key":"12648_CR12","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1111\/bph.15024","volume":"178","author":"BL Langdahl","year":"2021","unstructured":"Langdahl BL (2021) Overview of treatment approaches to osteoporosis. Br J Pharmacol 178(9):1891\u20131906. https:\/\/doi.org\/10.1111\/bph.15024","journal-title":"Br J Pharmacol"},{"issue":"1","key":"12648_CR13","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s11033-018-4532-x","volume":"46","author":"H Abdik","year":"2019","unstructured":"Abdik H, Av\u015far Abdik E, Demirci S, Do\u011fan A, Turan D, \u015eahin F (2019) The effects of bisphosphonates on osteonecrosis of jaw bone: a stem cell perspective. Mol Biol Rep 46(1):763\u2013776. https:\/\/doi.org\/10.1007\/s11033-018-4532-x","journal-title":"Mol Biol Rep"},{"issue":"3","key":"12648_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3109\/13697137.2012.656254","volume":"15","author":"VW Henderson","year":"2012","unstructured":"Henderson VW, Lobo RA (2012) Hormone therapy and the risk of stroke: perspectives 10 years after the Women\u2019s Health Initiative trials. Climacteric 15(3):229\u2013234. https:\/\/doi.org\/10.3109\/13697137.2012.656254","journal-title":"Climacteric"},{"issue":"9","key":"12648_CR15","doi-asserted-by":"publisher","first-page":"e10665","DOI":"10.1002\/jbm4.10665","volume":"6","author":"JH Krege","year":"2022","unstructured":"Krege JH, Gilsenan AW, Komacko JL, Kellier Steele N (2022) Teriparatide and osteosarcoma risk: history, science, elimination of boxed warning, and other label updates. J Bone Min Res Plus 6(9):e10665. https:\/\/doi.org\/10.1002\/jbm4.10665","journal-title":"J Bone Min Res Plus"},{"issue":"1","key":"12648_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/antiox14010081","volume":"14","author":"V Bertolucci","year":"2025","unstructured":"Bertolucci V, Ninomiya AF, Longato GB, Kaneko LO, Nonose N, Scariot PPM et al (2025) Bioactive compounds from propolis on bone homeostasis: A narrative review. Antioxidants 14(1):81. https:\/\/doi.org\/10.3390\/antiox14010081","journal-title":"Antioxidants"},{"issue":"08","key":"12648_CR17","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1142\/S0192415X20500871","volume":"48","author":"W-L Lin","year":"2020","unstructured":"Lin W-L, Lin P-Y, Hung Y-C, Hsueh T-P (2020) Benefits of herbal medicine on bone mineral density in osteoporosis: a meta-analysis of randomized controlled trials. Am J Chin Med 48(08):1749\u20131768. https:\/\/doi.org\/10.1142\/S0192415X20500871","journal-title":"Am J Chin Med"},{"issue":"12","key":"12648_CR18","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.3390\/molecules30122596","volume":"30","author":"K Wojtunik-Kulesza","year":"2025","unstructured":"Wojtunik-Kulesza K, Nizi\u0144ski P, Krajewska A, Oniszczuk T, Combrzy\u0144ski M, Oniszczuk A (2025) Therapeutic Potential of Ellagic Acid in Liver Diseases. Molecules 30(12):2596. https:\/\/doi.org\/10.3390\/molecules30122596","journal-title":"Molecules"},{"key":"12648_CR19","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3390\/antiox9080707","volume":"9","author":"S Alfei","year":"2020","unstructured":"Alfei S, Marengo B, Zuccari G (2020) Oxidative Stress, Antioxidant Capabilities, and Bioavailability: Ellagic Acid or Urolithins? Antioxidants 9:707. https:\/\/doi.org\/10.3390\/antiox9080707","journal-title":"Antioxidants"},{"key":"12648_CR20","doi-asserted-by":"publisher","unstructured":"Derosa G, Maffioli P, Sahebkar A (2016) Ellagic acid and its role in chronic diseases. Anti-inflamm Nutraceuticals Chronic Dis 473\u2013479. https:\/\/doi.org\/10.1007\/978-3-319-41334-1_20","DOI":"10.1007\/978-3-319-41334-1_20"},{"issue":"15","key":"12648_CR21","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1055\/a-0633-9492","volume":"84","author":"J-L R\u00edos","year":"2018","unstructured":"R\u00edos J-L, Giner RM, Mar\u00edn M, Recio MC (2018) A pharmacological update of ellagic acid. Planta Med 84(15):1068\u20131093. https:\/\/doi.org\/10.1055\/a-0633-9492","journal-title":"Planta Med"},{"issue":"23","key":"12648_CR22","doi-asserted-by":"publisher","first-page":"12577","DOI":"10.3390\/ijms252312577","volume":"25","author":"A Hanga-Farcas","year":"2024","unstructured":"Hanga-Farcas A, Fritea L, Filip GA, Clichici S, Vicas LG, Toma V-A et al (2024) The influence of juglans regia L. extract and ellagic acid on oxidative stress, inflammation, and bone regeneration biomarkers. Int J Mol Sci 25(23):12577. https:\/\/doi.org\/10.3390\/ijms252312577","journal-title":"Int J Mol Sci"},{"issue":"12","key":"12648_CR23","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.nutres.2012.09.018","volume":"32","author":"C-L Shen","year":"2012","unstructured":"Shen C-L, von Bergen V, Chyu M-C, Jenkins MR, Mo H, Chen C-H et al (2012) Fruits and dietary phytochemicals in bone protection. Nutr Res 32(12):897\u2013910. https:\/\/doi.org\/10.1016\/j.nutres.2012.09.018","journal-title":"Nutr Res"},{"issue":"9","key":"12648_CR24","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.archoralbio.2014.06.001","volume":"59","author":"MMJ Al-Obaidi","year":"2014","unstructured":"Al-Obaidi MMJ, Al-Bayaty FH, Al Batran R, Hassandarvish P, Rouhollahi E (2014) Protective effect of ellagic acid on healing alveolar bone after tooth extraction in rat\u2014a histological and immunohistochemical study. Arch Oral Biol 59(9):987\u2013999. https:\/\/doi.org\/10.1016\/j.archoralbio.2014.06.001","journal-title":"Arch Oral Biol"},{"issue":"9","key":"12648_CR25","doi-asserted-by":"publisher","first-page":"5951","DOI":"10.1002\/jcp.29520","volume":"235","author":"X Lin","year":"2020","unstructured":"Lin X, Yuan G, Li Z, Zhou M, Hu X, Song F et al (2020) Ellagic acid protects ovariectomy-induced bone loss in mice by inhibiting osteoclast differentiation and bone resorption. J Cell Physiol 235(9):5951\u20135961. https:\/\/doi.org\/10.1002\/jcp.29520","journal-title":"J Cell Physiol"},{"key":"12648_CR26","doi-asserted-by":"publisher","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 349. https:\/\/doi.org\/10.1136\/bmj.g7647","DOI":"10.1136\/bmj.g7647"},{"issue":"1","key":"12648_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-014-0579-0","volume":"14","author":"AM Methley","year":"2014","unstructured":"Methley AM, Campbell S, Chew-Graham C, McNally R, Cheraghi-Sohi S (2014) PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res 14(1):1\u201310. https:\/\/doi.org\/10.1186\/s12913-014-0579-0","journal-title":"BMC Health Serv Res"},{"key":"12648_CR28","doi-asserted-by":"publisher","first-page":"110852","DOI":"10.1016\/j.cbi.2023.110852","volume":"388","author":"H Dong","year":"2024","unstructured":"Dong H, Cao Y, Zou K, Shao Q, Liu R, Zhang Y et al (2024) Ellagic acid promotes osteoblasts differentiation via activating SMAD2\/3 pathway and alleviates bone mass loss in OVX mice. Chem Biol Interact 388:110852. https:\/\/doi.org\/10.1016\/j.cbi.2023.110852","journal-title":"Chem Biol Interact"},{"issue":"2","key":"12648_CR29","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11418-024-01859-2","volume":"79","author":"L Guo","year":"2025","unstructured":"Guo L, Wei P, Li S, Zhou L, Yan Y, Li D (2025) Ellagic acid prevents ovariectomy-induced bone loss and attenuates oxidative damage of osteoblasts by activating SIRT1. J Nat Med 79(2):371\u2013380. https:\/\/doi.org\/10.1007\/s11418-024-01859-2","journal-title":"J Nat Med"},{"issue":"4","key":"12648_CR30","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1017\/S0007114507837421","volume":"99","author":"Z Papoutsi","year":"2008","unstructured":"Papoutsi Z, Kassi E, Chinou I, Halabalaki M, Skaltsounis LA, Moutsatsou P (2008) Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483. Br J Nutr 99(4):715\u2013722. https:\/\/doi.org\/10.1017\/S0007114507837421","journal-title":"Br J Nutr"},{"key":"12648_CR31","doi-asserted-by":"publisher","first-page":"154745","DOI":"10.1016\/j.phymed.2023.154745","volume":"114","author":"Z Wu","year":"2023","unstructured":"Wu Z, Hu L, Ru K, Zhang W, Xu X, Liu S et al (2023) Ellagic acid inhibits CDK12 to increase osteoblast differentiation and alleviate osteoporosis in hindlimb-unloaded and ovariectomized mice. Phytomedicine 114:154745. https:\/\/doi.org\/10.1016\/j.phymed.2023.154745","journal-title":"Phytomedicine"},{"issue":"15","key":"12648_CR32","doi-asserted-by":"publisher","first-page":"15229","DOI":"10.1021\/acsomega.4c10642","volume":"10","author":"P Naidu","year":"2025","unstructured":"Naidu P, Das M, Hansda S, Prateeksha P, Howlader MSI, Siraj MA et al (2025) Mechanisms of Ellagic Acid (EA)-mediated osteogenic differentiation of human dental pulp-derived stem cells. ACS omega 10(15):15229\u201315242. https:\/\/doi.org\/10.1021\/acsomega.4c10642","journal-title":"ACS omega"},{"issue":"11","key":"12648_CR33","doi-asserted-by":"publisher","first-page":"9265","DOI":"10.3390\/nu7115465","volume":"7","author":"M Spilmont","year":"2015","unstructured":"Spilmont M, L\u00e9otoing L, Davicco MJ, Lebecque P, Miot-Noirault E, Pilet P et al (2015) Pomegranate Peel Extract Prevents Bone Loss in a Preclinical Model of Osteoporosis and Stimulates Osteoblastic Differentiation in Vitro. Nutrients 7(11):9265\u20139284. https:\/\/doi.org\/10.3390\/nu7115465","journal-title":"Nutrients"},{"key":"12648_CR34","doi-asserted-by":"publisher","first-page":"109235","DOI":"10.1016\/j.cbi.2020.109235","volume":"331","author":"H Xu","year":"2020","unstructured":"Xu H, Chen F, Liu T, Xu J, Li J, Jiang L et al (2020) Ellagic acid blocks RANKL\u2013RANK interaction and suppresses RANKL-induced osteoclastogenesis by inhibiting RANK signaling pathways. Chem Biol Interact 331:109235. https:\/\/doi.org\/10.1016\/j.cbi.2020.109235","journal-title":"Chem Biol Interact"},{"issue":"1","key":"12648_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12272-016-0790-0","volume":"40","author":"M Rantlha","year":"2017","unstructured":"Rantlha M, Sagar T, Kruger MC, Coetzee M, Deepak V (2017) Ellagic acid inhibits RANKL-induced osteoclast differentiation by suppressing the p38 MAP kinase pathway. Arch Pharm Res 40(1):79\u201387. https:\/\/doi.org\/10.1007\/s12272-016-0790-0","journal-title":"Arch Pharm Res"},{"issue":"Suppl 1","key":"12648_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s43465-023-01058-3","volume":"57","author":"SS Amarnath","year":"2023","unstructured":"Amarnath SS, Kumar V, Das SL (2023) Classification of osteoporosis. Indian J Orthop 57(Suppl 1):49\u201354. https:\/\/doi.org\/10.1007\/s43465-023-01058-3","journal-title":"Indian J Orthop"},{"issue":"2","key":"12648_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/17446651.2019.1575727","volume":"14","author":"L Colangelo","year":"2019","unstructured":"Colangelo L, Biamonte F, Pepe J, Cipriani C, Minisola S (2019) Understanding and managing secondary osteoporosis. Expert Rev Endocrinol Metab 14(2):111\u2013122. https:\/\/doi.org\/10.1080\/17446651.2019.1575727","journal-title":"Expert Rev Endocrinol Metab"},{"key":"12648_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jobcr.2021.11.008","volume":"12","author":"I Nirwana","year":"2022","unstructured":"Nirwana I, Munadziroh E, Yuliati A (2022) Ellagic acid and hydroxyapatite promote angiogenesis marker in bone defect. J Oral Biol Craniofac Res 12:116\u2013120. https:\/\/doi.org\/10.1016\/j.jobcr.2021.11.008","journal-title":"J Oral Biol Craniofac Res"},{"issue":"1","key":"12648_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41421-024-00689-6","volume":"10","author":"S Zhu","year":"2024","unstructured":"Zhu S, Chen W, Masson A, Li Y-P (2024) Cell signaling and transcriptional regulation of osteoblast lineage commitment, differentiation, bone formation, and homeostasis. Cell Discov 10(1):71. https:\/\/doi.org\/10.1038\/s41421-024-00689-6","journal-title":"Cell Discov"},{"issue":"18","key":"12648_CR40","doi-asserted-by":"publisher","first-page":"10102","DOI":"10.3390\/ijms251810102","volume":"25","author":"T Komori","year":"2024","unstructured":"Komori T (2024) Regulation of skeletal development and maintenance by Runx2 and Sp7. Int J Mol Sci 25(18):10102. https:\/\/doi.org\/10.3390\/ijms251810102","journal-title":"Int J Mol Sci"},{"issue":"1","key":"12648_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13018-015-0152-5","volume":"10","author":"S Mollazadeh","year":"2015","unstructured":"Mollazadeh S, Fazly Bazzaz BS, Kerachian MA (2015) Role of apoptosis in pathogenesis and treatment of bone-related diseases. J Orthop Surg Res 10(1):15. https:\/\/doi.org\/10.1186\/s13018-015-0152-5","journal-title":"J Orthop Surg Res"},{"key":"12648_CR42","doi-asserted-by":"publisher","first-page":"1611932","DOI":"10.3389\/fimmu.2025.1611932","volume":"16","author":"J Luo","year":"2025","unstructured":"Luo J, Li L, Shi W, Xu K, Shen Y, Dai B (2025) Oxidative stress and inflammation: roles in osteoporosis. Front Immunol 16:1611932. https:\/\/doi.org\/10.3389\/fimmu.2025.1611932","journal-title":"Front Immunol"},{"issue":"1","key":"12648_CR43","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s11658-023-00489-y","volume":"28","author":"J Riegger","year":"2023","unstructured":"Riegger J, Schoppa A, Ruths L, Haffner-Luntzer M, Ignatius A (2023) Oxidative stress as a key modulator of cell fate decision in osteoarthritis and osteoporosis: a narrative review. Cell Mol Biol Lett 28(1):76. https:\/\/doi.org\/10.1186\/s11658-023-00489-y","journal-title":"Cell Mol Biol Lett"},{"issue":"14","key":"12648_CR44","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.7150\/ijbs.46627","volume":"16","author":"S Wang","year":"2020","unstructured":"Wang S, Deng Z, Ma Y, Jin J, Qi F, Li S et al (2020) The role of autophagy and mitophagy in bone metabolic disorders. Int J Biol Sci 16(14):2675. https:\/\/doi.org\/10.7150\/ijbs.46627","journal-title":"Int J Biol Sci"},{"issue":"1","key":"12648_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4248\/BR201301003","volume":"1","author":"F Xu","year":"2013","unstructured":"Xu F, Teitelbaum SL (2013) Osteoclasts: new insights. Bone Res 1(1):11\u201326. https:\/\/doi.org\/10.4248\/BR201301003","journal-title":"Bone Res"},{"issue":"11","key":"12648_CR46","doi-asserted-by":"publisher","first-page":"jcs216267","DOI":"10.1242\/jcs.216267","volume":"131","author":"M Pereira","year":"2018","unstructured":"Pereira M, Petretto E, Gordon S, Bassett JHD, Williams GR, Behmoaras J (2018) Common signalling pathways in macrophage and osteoclast multinucleation. J Cell Sci 131(11):jcs216267. https:\/\/doi.org\/10.1242\/jcs.216267","journal-title":"J Cell Sci"},{"issue":"22","key":"12648_CR47","doi-asserted-by":"publisher","first-page":"16175","DOI":"10.3390\/ijms242216175","volume":"24","author":"T Jiang","year":"2023","unstructured":"Jiang T, Xia T, Qiao F, Wang N, Jiang Y, Xin H (2023) Role and regulation of transcription factors in osteoclastogenesis. Int J Mol Sci 24(22):16175. https:\/\/doi.org\/10.3390\/ijms242216175","journal-title":"Int J Mol Sci"},{"issue":"10","key":"12648_CR48","doi-asserted-by":"publisher","first-page":"706","DOI":"10.14348\/molcells.2017.0225","volume":"40","author":"JH Park","year":"2017","unstructured":"Park JH, Lee NK, Lee SY (2017) Current understanding of RANK signaling in osteoclast differentiation and maturation. Mol Cells 40(10):706\u2013713. https:\/\/doi.org\/10.14348\/molcells.2017.0225","journal-title":"Mol Cells"},{"issue":"1","key":"12648_CR49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41421-025-00853-6","volume":"12","author":"S Zhu","year":"2026","unstructured":"Zhu S, Yan M-Q, Masson A, Chen W, Li Y-P (2026) Cell signaling and transcriptional regulation of osteoclast lineage commitment, differentiation, bone resorption and diseases. Cell Discov 12(1):6. https:\/\/doi.org\/10.1038\/s41421-025-00853-6","journal-title":"Cell Discov"},{"issue":"5","key":"12648_CR50","doi-asserted-by":"publisher","first-page":"6605","DOI":"10.3892\/mmr.2018.8698","volume":"17","author":"G Luo","year":"2018","unstructured":"Luo G, Li F, Li X, Wang Z, Zhang B (2018) TNF\u2013\u03b1 and RANKL promote osteoclastogenesis by upregulating RANK via the NF\u2013\u03baB pathway. Mol Med Rep 17(5):6605\u20136611. https:\/\/doi.org\/10.3892\/mmr.2018.8698","journal-title":"Mol Med Rep"},{"issue":"7","key":"12648_CR51","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.3390\/ijms26072893","volume":"26","author":"AN Shuid","year":"2025","unstructured":"Shuid AN, Abdul Nasir NA, Ab Azis N, Shuid AN, Razali N, Ahmad Hairi H et al (2025) A systematic review on the molecular mechanisms of resveratrol in protecting against osteoporosis. Int J Mol Sci 26(7):2893. https:\/\/doi.org\/10.3390\/ijms26072893","journal-title":"Int J Mol Sci"},{"key":"12648_CR52","doi-asserted-by":"publisher","first-page":"1249418","DOI":"10.3389\/fphar.2023.1249418","volume":"14","author":"S Yang","year":"2023","unstructured":"Yang S, Sun Y, Kapilevich L, Zhang X, Huang Y (2023) Protective effects of curcumin against osteoporosis and its molecular mechanisms: a recent review in preclinical trials. Front Pharmacol 14:1249418. https:\/\/doi.org\/10.3389\/fphar.2023.1249418","journal-title":"Front Pharmacol"},{"issue":"10","key":"12648_CR53","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.3390\/app10103353","volume":"10","author":"G Zuccari","year":"2020","unstructured":"Zuccari G, Baldassari S, Ailuno G, Turrini F, Alfei S, Caviglioli G (2020) Formulation strategies to improve oral bioavailability of ellagic acid. Appl Sci 10(10):3353. https:\/\/doi.org\/10.3390\/app10103353","journal-title":"Appl Sci"},{"issue":"38","key":"12648_CR54","doi-asserted-by":"publisher","first-page":"382001","DOI":"10.1088\/1361-6528\/ab912c","volume":"31","author":"C Ceci","year":"2020","unstructured":"Ceci C, Graziani G, Faraoni I, Cacciotti I (2020) Strategies to improve ellagic acid bioavailability: from natural or semisynthetic derivatives to nanotechnological approaches based on innovative carriers. Nanotechnology 31(38):382001. https:\/\/doi.org\/10.1088\/1361-6528\/ab912c","journal-title":"Nanotechnology"},{"key":"12648_CR55","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ejpb.2020.11.004","volume":"159","author":"I Nyamba","year":"2021","unstructured":"Nyamba I, Lechanteur A, Semd\u00e9 R, Evrard B (2021) Physical formulation approaches for improving aqueous solubility and bioavailability of ellagic acid: A review. Eur J Pharm Biopharm 159:198\u2013210. https:\/\/doi.org\/10.1016\/j.ejpb.2020.11.004","journal-title":"Eur J Pharm Biopharm"},{"key":"12648_CR56","doi-asserted-by":"publisher","unstructured":"Mady FM, Shaker MA (2017) Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles. Int J Nanomed 7405\u20137417. https:\/\/doi.org\/10.2147\/IJN.S147740","DOI":"10.2147\/IJN.S147740"},{"issue":"01","key":"12648_CR57","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1055\/s-0040-1714039","volume":"15","author":"AS Wardhana","year":"2021","unstructured":"Wardhana AS, Nirwana I, Budi HS, Surboyo MDC (2021) Role of hydroxyapatite and ellagic acid in the osteogenesis. Eur J Dent 15(01):8\u201312. https:\/\/doi.org\/10.1055\/s-0040-1714039","journal-title":"Eur J Dent"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12648-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12648-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12648-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T21:02:43Z","timestamp":1788642163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12648-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,5]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12648"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12648-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,5]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1531"}}